Sulzer Suit Seeks Damages From Medtronic On Bone Dowel Regulatory Stance
This article was originally published in The Gray Sheet
Executive Summary
Medtronic misrepresented Sulzer Medica's position on possible FDA regulation of bone dowel implants of human origin in "inflammatory" letters to spine surgeons, a suit filed Sept. 8 in Minneapolis federal court alleges.